Ledger.Open graph →
SEC Form D · filed July 11, 2025

Reprise Biomedical, Inc

Offering
$7.0M
Sold
$6.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Plymouth, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Jake Isenburg · Plymouth, MNExecCarrie Powers · Plymouth, MNExec · DirectorRonald Eibensteiner · Eden Prairie, MNDirectorPhil Nalbone · Plymouth, MNDirectorHoward Root · Plymouth, MNDirectorErwin Kelen · BLOOMINGTON, MNDirectorJerrod Krueger · Plymouth, MNExecSteve Jagodzinski · Plymouth, MNExecHeather Kotila · Plymouth, MNExecGreg Smock · Plymouth, MNExecTom Kouchoukos · Plymouth, MNExecErwin Kelen · Minneapolis, MNDirectorAlan Woldt · Plymouth, MNDirectorJeff Duncan · Plymouth, MNExecJake Isenburg · Plymouth, MNExecCarrie Powers · EDEN PRAIRIE, MNExec · DirectorRonald Eibensteiner · Eden Prairie, MNDirectorPhil Nalbone · Plymouth, MNDirectorHoward Root · EDEN PRAIRIE, MNDirectorTom Kouchoukos · Plymouth, MNExecErwin Kelen · Plymouth, MNDirectorAlan Woldt · Plymouth, MNDirectorJerrod Krueger · Plymouth, MNExecJeff Duncan · Plymouth, MNExecSteve Jagodzinski · Plymouth, MNExecHeather Kotila · Plymouth, MNExecGreg Smock · Plymouth, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗